PSA vs SNSE · rev $4.82B vs $18.6M cap
PSA (PSA) versus Sensei Biotherapeutics Inc (SNSE) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Sensei Biotherapeutics Inc (SNSE) is a biotechnology company listed on NASDAQ.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
SNSE does not have a complete income-statement cache yet.
PSA currently screens at market cap $0. SNSE currently screens at market cap $18.6M.
Not investment advice. Open the PSA and SNSE stock pages for the full models.
Not investment advice.